Work

Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies

Year: 2018

Type: article

Study design: Systematic Review

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-018-4996-3

Authors: Raquel N. Rozner, Azael Freites-Martinez, Jerry Shapiro, Eliza B. Geer, Shari Goldfarb, Mario E. Lacouture

Institutions: Memorial Sloan Kettering Cancer Center, New York University, Weill Cornell Medicine

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2900536734

FWCI: 2.08

Cites: 116

Cited by: 45

Related to: 10